An Open-label Clinical Trial to Evaluate the Immunity Persistence of Live Attenuated Varicella Vaccine at 6 and 10 Years After Booster Dose Immunization With Live Attenuated Varicella Vaccine
Latest Information Update: 29 Jan 2025
At a glance
- Drugs Varicella zoster virus vaccine Sinovac (Dalian) Vaccine Technology (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors Sinovac (Dalian) Vaccine Technology
Most Recent Events
- 27 Jan 2025 Planned End Date changed from 1 Sep 2028 to 1 Dec 2031.
- 27 Jan 2025 Planned primary completion date changed from 1 Sep 2026 to 1 Dec 2028.
- 27 Jan 2025 Status changed from not yet recruiting to recruiting.